COMMUNIQUÉS West-GlobeNewswire

-
iTeos Therapeutics Appoints Joanne Jenkins Lager, M.D., as Chief Medical Officer
26/03/2019 -
Oxford Biomedica notes the Japanese approval of Kymriah® (tisagenlecleucel), the first CAR-T cell therapy authorised in Asia
26/03/2019 -
Cambrex Doubles cGMP Liquid Filling Capacity at its Mirabel, Québec Facility
26/03/2019 -
MediWound Files Annual Report on Form 20-F for the Year Ended December 31, 2018
26/03/2019 -
Notification from Oasmia Pharmaceutical AB
26/03/2019 -
Matinas BioPharma to Announce Full-Year 2018 Operational and Financial Results on April 2, 2019
26/03/2019 -
Blissco Signs Agreement to Supply New Brunswick with Premium Cannabis
26/03/2019 -
Predictive Technology Group Completes Acquisition of Taueret Laboratories
26/03/2019 -
iCAD to Present Corporate Overview at the Jefferies 2019 Radiation Oncology & Energy-Based Therapeutics Summit
26/03/2019 -
Kezar Life Sciences Reports Fourth Quarter and Year End 2018 Financial Results and Provides Business Update
26/03/2019 -
Neuronetics to Present at the 18th Annual Needham & Company Healthcare Conference
26/03/2019 -
Aura Announces Appointment of Alain Dobkin to its Board of Directors
26/03/2019 -
D.A. Wallach Joins BioSig Technologies Advisory Board
26/03/2019 -
MediPharm Labs Expands Legal Team Adding Cannabis Expertise and Announces Participation at Upcoming Conferences
26/03/2019 -
BeyondSpring’s Lead Asset, Plinabulin, Shifts the Balance of Macrophages Towards Anti-Cancer M1s
26/03/2019 -
Onconova Therapeutics, Inc. Reports Business Highlights and Full Year 2018 Financial Results
26/03/2019 -
Immunotherapy Company Enlivex Therapeutics Announces Nasdaq Listing Under Symbol “ENLV” and Closing of Private Placement of Ordinary Shares Priced at $12.25 Per Share
26/03/2019 -
Translate Bio Granted U.S. Patent Relating to Messenger RNA (mRNA) Delivery
26/03/2019 -
ProMIS Neurosciences to Participate in Microcap Spring Investor Summit 2019
26/03/2019
Pages